Prevalence of Potential Drug- Drug Interaction
Tracks 14: Prevalence of Potential Drug- Drug Interaction
The objective of this study is to estimate the prevalence and describe the characteristics of pDDIs in medical prescriptions of hospitalized surgical patients. In this cross-sectional study, we analyzed 370 medical prescriptions from the surgery unit of a Mexican public teaching hospital. The identification and classification of potential drug-drug interactions were performed with the Micromedex 2.0 electronic drug information database. Results were analyzed with descriptive statistics and we estimated OR (odds ratio) to determine associated risk factors.
Related Conference of Prevalence of Potential Drug- Drug Interaction
August 06-07, 2024
27th World Congress on Nursing, Pharmacology and Healthcare
Aix-en-Provence, France
August 08-09, 2024
30th International Conference on Advanced Clinical Research and Clinical Trials
London, UK
September 11-12, 2024
9th International Conference on Future Pharma and Innovations
Amsterdam, Netherlands
September 12-13, 2024
25th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
Rome, Italy
September 18-19, 2024
3rd World Congress on Medicinal Chemistry and Computer Aided Drug Design
Amsterdam, Netherlands
October 17-18, 2024
4th International Conference and Expo on Biopharmaceutics and Biologic Drugs
London, UK
October 31-01, 2024
27th International Conference and Exhibition on Pharmaceutical Formulations
Amsterdam, Netherlands
November 25-26, 2024
10th International Conference on Antimicrobials & Antibiotic Resistance
Vancouver, Canada
November 26-27, 2024
3rd World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland
November 28-29, 2024
41st International Conference on Drug Discovery and Drug delivery system
Paris, France
November 28-29, 2024
16th International Conference on Biosimilars and Pharma Innovations
Bali, Indonesia
December 12-13, 2024
12th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Rome, Italy
March 13-14, 2025
8th International on Pharmacy and Pharmaceutical Conference
Prague, Czech Republic
April 07-08, 2025
4th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems
Vancouver, Canada
June 16-17, 2025
18th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Frankfurt, Germany
June 23-24, 2025
25th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
Aix-en-Provence, France
Prevalence of Potential Drug- Drug Interaction Conference Speakers
Recommended Sessions
- Pharmaceutical Research and Development
- Adverse Drug Reactions
- Causality Assessment
- Clinical Data Management
- Clinical Database Management
- Clinical Research and Statistics
- Clinical Research Nursing
- Clinical Trial Protocols
- Clinical Trials Pharmacovigilance
- Drug Delivery Technologies & Drug Designing and Development
- Drug repurposing to treat Viruses: COVID-19
- Drug Safety
- Drug Safety and Pharmacovigilance
- Global Clinical Trials
- Importance of Audit in Pharmaceutical Industry
- Medical Devices for Drug Delivery
- Pharma Market Research
- Pharmaceutical Nanotechnology: Challenges and Opportunities
- Pharmacoeconomics
- Pharmacokinetics and Pharmacodynamics in Drugs
- Pharmacovigilance and Clinical Trials
- Pharmacovigilance and Cosmetovigilance
- Pharmacovigilance and Risk Management
- Pharmacovigilance Practice
- Pharmacovigilance Significance and Scope
- Prevalence of Potential Drug- Drug Interaction
- Recent trends in Pharma and Technology
- Regulatory Authority Compliance
- Track: 29 Oncology Clinical Research
- Track:30 Risk assessment and management in clinical trials
- Use of Nanoparticles in DDS and Newer Methodologies
Related Journals
Are you interested in
- Active Pharmaceutical Ingredients - MedTech-2024 (Switzerland)
- Acupuncture - Naturalproducts 2024 (Italy)
- Adaptive Trial Model - Clinical Trials Congress-2024 (France)
- Advanced Drug Delivery System - BIOSIMILARS-2024 (Indonesia)
- Advancements in drug delivery systems - Pharmaceutica-2025 (Canada)
- Advancements in Drug Discovery - Pharmacology-2024 (France)
- Advancements in Psychology Research Methods - Clinical Research 2024 (UK)
- Advances in Controlled Release Formulations - Pharmaceutica-2025 (Canada)
- Advances in Vaccine Delivery - Drug Delivery-2024 (France)
- Advancing Research for rare diseases - ORPHAN DRUGS 2024 (France)
- Adverse Drug Reactions - Pharmacology 2024 (Netherlands)
- Alternative Medicine and Complementary Medicine - Naturalproducts 2024 (Italy)
- Analyses and Quality Control for Pharmaceuticals - Drug Safety 2024 (France)
- Analytical strategies for pharmaceutical products - MedTech-2024 (Switzerland)
- Analytical Techniques in Bioequivalence Assessment - BABE 2024 (UAE)
- Angina Pectoris - Cardiovascular-2024 (France)
- Antibiotic Prophylaxis - Antibiotics Resistance 2024 (Canada)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics Resistance 2024 (Canada)
- Antibiotic-resistant Bacterial infections - Antibiotics Resistance 2024 (Canada)
- Antibiotics - Antibiotics Resistance 2024 (Canada)
- Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2024 (Canada)
- Antimicrobial Peptides - Antibiotics Resistance 2024 (Canada)
- Antimicrobial Therapy - Antibiotics Resistance 2024 (Canada)
- Applied Microbiology - Biotech-2025 (France)
- Applied pharmacology - Euro Pharmacology 2024 (UK)
- Artificial Intelligence (AI) - Personalizedmedicine-2024 (Switzerland)
- Artificial Intelligence and Machine Learning in Drug Delivery Optimization - Pharmaceutica-2025 (Canada)
- Atrial Fibrillation - Cardiovascular-2024 (France)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- BCS and IVIVC Based Biowaivers - Eurobiosimilars 2025 (France)
- Big data analytics and Pharma - Future Pharma 2024 (Netherlands)
- Bio Chemical Pharmacology - Pharmacology 2024 (Netherlands)
- Bio Molecular Dynamics - Biotech-2025 (France)
- Bio-Pharmaceutics - PHARMACEUTICA 2024 (Italy)
- Bioavailability Enhancement Strategies - BABE 2024 (UAE)
- Bioequivalence and Bioavailability - MedTech-2024 (Switzerland)
- Bioequivalence of Generic Drugs and Biosimilars - BABE 2024 (UAE)
- Bioequivalence of Narrow Therapeutic Index Drugs - BABE 2024 (UAE)
- Bioequivalence Study Designs and Methodologies - BABE 2024 (UAE)
- Bioethics and Regulatory Compliance - Clinical Research 2024 (UK)
- Bioethics and Regulatory Compliance - Clinical-Trials-2024 (Canada)
- Bioinformatics in Drug Discovery - PHARAMACEUTICAL CONF 2024 (France)
- Biological Medicine - BIOSIMILARS-2024 (Indonesia)
- Biological Medicine - Eurobiosimilars 2025 (France)
- Biologics & Biosimilars - PHARMACEUTICA 2024 (Italy)
- Biologics and Biosimilars - Pharmaceutica-2025 (Canada)
- Biomarker Discovery and Drug Development - Clinical Trials Congress-2024 (France)
- Biomarkers - Personalizedmedicine-2024 (Switzerland)
- Biomaterials and Biodegradable Polymers in Drug Delivery - Drug Delivery-2024 (France)
- Biomaterials in Drug Delivery - PHARMACEUTICA 2024 (Italy)
- Biomedical Devices Clinical Research - Clinical Research 2024 (UK)
- Biomedical Toxicology - Euro Pharmacology 2024 (UK)
- Biopharmaceutical Formulation Development - Drug Delivery-2024 (France)
- Biopharmaceutical Informatics - BIOSIMILARS-2024 (Indonesia)
- Biopharmaceutical Informatics - Eurobiosimilars 2025 (France)
- Biopharmaceuticals, Biomolecules, and Therapeutics - Drug Safety 2024 (France)
- Biopharmaceutics and Drug Disposition - Pharmaceutica-2025 (Canada)
- Biosimilars - BABE 2024 (UAE)
- Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Biosimilars - Biotech-2025 (France)
- Biosimilars Approval to Biogenerics in Clinical Practice - Eurobiosimilars 2025 (France)
- Biosimilars Development in Markets - Eurobiosimilars 2025 (France)
- Biosimilars Market and Cost Analysis - Eurobiosimilars 2025 (France)
- Biosimilars Research Pipeline - Eurobiosimilars 2025 (France)
- Biotechnology and Microbiology in Pharmaceuticals - Drug Safety 2024 (France)
- Biotechnology in Pharmacotherapy - Pharmacology-2024 (France)
- Biowaivers - BABE 2024 (UAE)
- Biowaivers and Regulatory Exemptions - BABE 2024 (UAE)
- Cancer Biotechnology - Biotech-2025 (France)
- Cancer Clinical Research - Clinical Trials Congress-2024 (France)
- Cardiac Surgery - Cardiovascular-2024 (France)
- Cardio Vascular Pharmacology - Pharmacology 2024 (Netherlands)
- Cardio-Oncology - Cardiovascular-2024 (France)
- Cardiovascular Medicine - Cardiovascular-2024 (France)
- Cellular Targeting and subcellular Delivery - Drug Safety 2024 (France)
- Challenges and Future Innovations of Traditional Medicine - Naturalproducts 2024 (Italy)
- Challenges in Biosimilars Pharmacovigilance - Eurobiosimilars 2025 (France)
- Challenges in Rare Diseases - ORPHAN DRUGS 2024 (France)
- Chemical and Analytical Strategies for Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Chemical and Analytical Strategies for Biosimilars - Eurobiosimilars 2025 (France)
- Chronic Disease Management and Palliative Care - NURSING PHARMACOLOGY 2024 (France)
- Clinical and Hospital Pharmacy - Future Pharma 2024 (Netherlands)
- Clinical and Medical Case Reports - Clinical Research 2024 (UK)
- Clinical Cases in Cardiology - Cardiovascular-2024 (France)
- Clinical Data Management and Analytics - Clinical-Trials-2024 (Canada)
- Clinical Data Management and Statistics - Clinical Research 2024 (UK)
- Clinical Data Strategy and Analytics - Clinical Trials Congress-2024 (France)
- Clinical Operations & Project Management - Clinical-Trials-2024 (Canada)
- Clinical Pharmacology - Euro Pharmacology 2024 (UK)
- Clinical Pharmacology and Pharmacotherapeutics - Euro Pharmacology 2024 (UK)
- Clinical Pharmacology and Receptor Therapy - Clinical Trials Congress-2024 (France)
- Clinical Pharmacovigilance and Drug Safety - PHARAMACEUTICAL CONF 2024 (France)
- Clinical Pharmacy and Pharmacotherapeutics - Pharmacology 2024 (Netherlands)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2024 (Switzerland)
- Clinical Research & Clinical Trials: Academic Perspective - Clinical-Trials-2024 (Canada)
- Clinical Research Nursing - Clinical Research 2024 (UK)
- Clinical Research Statistics - Pharmacology 2024 (Netherlands)
- Clinical Supply Management - Clinical-Trials-2024 (Canada)
- Clinical Toxicology - Euro Pharmacology 2024 (UK)
- Clinical Trial Auditing - Clinical Trials Congress-2024 (France)
- Clinical Trial Forecasting, Budgeting and Contracting - Clinical-Trials-2024 (Canada)
- Clinical Trial Site Selection and Management - Clinical-Trials-2024 (Canada)
- Clinical Trials - Clinical Trials Congress-2024 (France)
- Clinical Trials - Personalizedmedicine-2024 (Switzerland)
- Clinical Trials & Pharmacovigilance - Clinical Trials Congress-2024 (France)
- Clinical Trials and Clinical Research - PHARMACEUTICA 2024 (Italy)
- Clinical Trials and Drug Evaluation - PHARAMACEUTICAL CONF 2024 (France)
- Clinical trials and Pharmacovigilance - MedTech-2024 (Switzerland)
- Clinical Trials in Developing Countries - Clinical Research 2024 (UK)
- Clinical Trials of Antibiotics - Antibiotics Resistance 2024 (Canada)
- Clinical Trials on Different Diseases - Clinical Research 2024 (UK)
- Clinical Trials on different Diseases - Clinical-Trials-2024 (Canada)
- Computational Chemistry in Drug Design - PHARAMACEUTICAL CONF 2024 (France)
- Computer Assisted Drug Design - Biotech-2025 (France)
- Computer Assisted Drug Design - Biotech-2025 (France)
- Consequences of Brexit on Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Consequences of Brexit on Biosimilars - Eurobiosimilars 2025 (France)
- CRO, Sponsorship & Outsourcing for Clinical Trials - Clinical-Trials-2024 (Canada)
- Crude Drugs and Plant Products - Naturalproducts 2024 (Italy)
- Current Advances in Pharmacology - Euro Pharmacology 2024 (UK)
- Current Agency Expectations for Approval for Biosimilars - Eurobiosimilars 2025 (France)
- Current Challenges in Developing Biosimilars - Eurobiosimilars 2025 (France)
- Current research in antibiotic resistance - Antibiotics Resistance 2024 (Canada)
- Data Analytics - Personalizedmedicine-2024 (Switzerland)
- Decentralized Clinical Trials - Clinical Trials Congress-2024 (France)
- Delivery of Medicine via Inhalation - Drug Safety 2024 (France)
- Design of Clinical Studies and Trials - Clinical Research 2024 (UK)
- Developing Alternatives to Antibiotics - Antibiotics Resistance 2024 (Canada)
- Development and Production of Pharmaceutical Products - Drug Safety 2024 (France)
- Devices / CRT / ICD / Surgery - Cardiovascular-2024 (France)
- Diagnostics & Medical Devices - Biotech-2025 (France)
- Digital Health - Personalizedmedicine-2024 (Switzerland)
- Digital Health and Pharmacology - Pharmacology-2024 (France)
- Digital Marketing in Pharma Industry - Future Pharma 2024 (Netherlands)
- Digital Pharma - BIOSIMILARS-2024 (Indonesia)
- Disease Prevention - Personalizedmedicine-2024 (Switzerland)
- Drug delivery - Drug Devilvery 2024 (UAE)
- Drug Delivery and Development - Eurobiosimilars 2025 (France)
- Drug Delivery and Gene Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery Challenges in Neurological Disorders - Drug Delivery-2024 (France)
- Drug Delivery for Cardiovascular Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery in Cancer Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery in Infectious Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery Strategies for Cancer Therapy - Drug Delivery-2024 (France)
- Drug Delivery Technology - Drug Devilvery 2024 (UAE)
- Drug Delivery Technology - BIOSIMILARS-2024 (Indonesia)
- Drug Delivery Technology and Vaccine Design - Drug Safety 2024 (France)
- Drug Delivery through Blood-Brain Barrier (BBB) - Clinical Trials Congress-2024 (France)
- Drug Delivery Using Peptides and Proteins - Drug Safety 2024 (France)
- Drug Design and development - PHARAMACEUTICAL CONF 2024 (France)
- Drug design and development - Drug Devilvery 2024 (UAE)
- Drug Design and Development - Formulations 2024 (Netherlands)
- Drug Designing - Clinical Trials Congress-2024 (France)
- Drug Discovery - Clinical Trials Congress-2024 (France)
- Drug Discovery and Development - Clinical-Trials-2024 (Canada)
- Drug Discovery and Development - Future Pharma 2024 (Netherlands)
- Drug discovery and NCEs - MedTech-2024 (Switzerland)
- Drug Discovery and Novel Delivery Technologies - Antibiotics Resistance 2024 (Canada)
- Drug Formulation - BIOSIMILARS-2024 (Indonesia)
- Drug Formulation Procedures - Formulations 2024 (Netherlands)
- Drug Metabolism and Toxicology - PHARAMACEUTICAL CONF 2024 (France)
- Drug Product Manufacturing - Formulations 2024 (Netherlands)
- Drug Repurposing and Drug Discovery Strategies - PHARAMACEUTICAL CONF 2024 (France)
- Drug Repurposing and Drug Rediscovery - Pharmacology-2024 (France)
- Drug Repurposing and Drug Rediscovery - Drug Delivery-2024 (France)
- Drug Research and Evaluation - Drug Safety 2024 (France)
- Drug Safety - Drug Safety 2024 (France)
- Drug Safety Testing - Pharmacology 2024 (Netherlands)
- Drug Screening and Discovery - Pharmacology 2024 (Netherlands)
- Drug Synthesis and Formulation - PHARAMACEUTICAL CONF 2024 (France)
- Drug Targeting and Design - PHARMACEUTICA 2024 (Italy)
- Drug Targeting and Design - Pharmaceutica-2025 (Canada)
- Drug Transporters and Bioequivalence - BABE 2024 (UAE)
- Ecopharmacovigilance - Pharmacology 2024 (Netherlands)
- Ecopharmacovigilance - Euro Pharmacology 2024 (UK)
- Electronic Health Records (EHRs) - Personalizedmedicine-2024 (Switzerland)
- Emerging Biosimilars in Therapeutics - Eurobiosimilars 2025 (France)
- Emerging Technologies in Drug Discovery - Drug Delivery-2024 (France)
- Encapsulated Drugs - BIOSIMILARS-2024 (Indonesia)
- Enrollment Planning and Patient Recruitment - Clinical-Trials-2024 (Canada)
- Entrepreneurs Investment Meet - ORPHAN DRUGS 2024 (France)
- Entrepreneurs Investment Meet - Formulations 2024 (Netherlands)
- Environmental Toxicology - Euro Pharmacology 2024 (UK)
- Epidemiology and Public Health - Clinical Research 2024 (UK)
- Factors that affect the quality and efficiency of clinical trials - Clinical Trials Congress-2024 (France)
- Food-Drug Interactions in Bioequivalence - BABE 2024 (UAE)
- Forensic Toxicology - Pharmacology 2024 (Netherlands)
- Forensic Toxicology - Euro Pharmacology 2024 (UK)
- Formulation Factors Influencing Bioavailability - BABE 2024 (UAE)
- Formulation Strategies for Follow-on Biologics - Eurobiosimilars 2025 (France)
- Formulations and NNDS - MedTech-2024 (Switzerland)
- Fundamentals of Bioavailability and Bioequivalence Studies - BABE 2024 (UAE)
- Future of Clinical Trials - Clinical Research 2024 (UK)
- Future of Clinical Trials and Technology Innovations - Clinical-Trials-2024 (Canada)
- Future Perspectives in Drug Discovery and Delivery - Drug Delivery-2024 (France)
- Gaming and Abuse of Orphan Drugs - ORPHAN DRUGS 2024 (France)
- Gaseous Dosage Forms - Formulations 2024 (Netherlands)
- Gene Therapy and RNA-based Therapeutics - Drug Delivery-2024 (France)
- General Considerations in Dosage Forms - Formulations 2024 (Netherlands)
- Genetic Testing - Personalizedmedicine-2024 (Switzerland)
- Genomics - Personalizedmedicine-2024 (Switzerland)
- Genomics and Proteomics of Rare Disease - ORPHAN DRUGS 2024 (France)
- Geriatric Nursing and Age-Related Care - NURSING PHARMACOLOGY 2024 (France)
- Global Health Challenges and Healthcare Equity - NURSING PHARMACOLOGY 2024 (France)
- Global Rare Diseases and Orphan Drug Market - ORPHAN DRUGS 2024 (France)
- Globalization of Biosimilars - Eurobiosimilars 2025 (France)
- Globalization of Clinical Trials - Clinical-Trials-2024 (Canada)
- Green and Community Pharmacy - Future Pharma 2024 (Netherlands)
- Health Equity - Personalizedmedicine-2024 (Switzerland)
- Health Toxicology - Euro Pharmacology 2024 (UK)
- Healthcare Policy and Management - NURSING PHARMACOLOGY 2024 (France)
- Heart Transplant Surgery - Cardiovascular-2024 (France)
- Herbal Medicine - Naturalproducts 2024 (Italy)
- Hereditary Angioedema: Diagnosis, Clinical Implications - Clinical Trials Congress-2024 (France)
- Homeopathic and Ayurvedic Medicines - Naturalproducts 2024 (Italy)
- Hypertension - Cardiovascular-2024 (France)
- Hypertrophic Cardiomyopathy - Cardiovascular-2024 (France)
- Imaging Research - Clinical Trials Congress-2024 (France)
- Immunology & Vaccines - Antibiotics Resistance 2024 (Canada)
- Immunopharmacology - Pharmacology 2024 (Netherlands)
- Immunopharmacology - Euro Pharmacology 2024 (UK)
- Immunopharmacology of Autoimmune Disorders - Pharmacology-2024 (France)
- In Vitro-In Vivo Correlation - BABE 2024 (UAE)
- Industrial Bioproceses for Drug Production and Development - Biotech-2025 (France)
- Industrial Pharmacy and Physical pharmacy - Future Pharma 2024 (Netherlands)
- Infectious Diseases - Antibiotics Resistance 2024 (Canada)
- Innovations in clinical study designs - Clinical-Trials-2024 (Canada)
- Innovations in Clinical Trials - Clinical Research 2024 (UK)
- Innovations in Nursing Technology and Informatics - NURSING PHARMACOLOGY 2024 (France)
- Innovations in Oral Drug Delivery Systems - Drug Delivery-2024 (France)
- Innovations in Pre-clinical Research - Clinical Research 2024 (UK)
- Innovative Clinical Approach in Biosimilars - Eurobiosimilars 2025 (France)
- Integrative Medicine and Holistic Healthcare - NURSING PHARMACOLOGY 2024 (France)
- Intellectual Property Rights - BIOSIMILARS-2024 (Indonesia)
- Intellectual Property Rights - Eurobiosimilars 2025 (France)
- Intellectual property rights and regulatory issues - Drug Safety 2024 (France)
- Interventional Cardiology - Cardiovascular-2024 (France)
- Latest technologies in Biomedical Research - Clinical Research 2024 (UK)
- Legal Issues and BPCI Act - Eurobiosimilars 2025 (France)
- Lifestyle Medicine - Personalizedmedicine-2024 (Switzerland)
- Liquid Dosage Forms - Formulations 2024 (Netherlands)
- Living with a Rare Disease - ORPHAN DRUGS 2024 (France)
- Marine Natural Products - Naturalproducts 2024 (Italy)
- Mechanism and Evolution of Antibiotic Resistance - Antibiotics Resistance 2024 (Canada)
- Medical and Clinical Case Reports - Clinical-Trials-2024 (Canada)
- Medical Devices for Drug Delivery - PHARMACEUTICA 2024 (Italy)
- Medical Imaging in Clinical Research - Clinical-Trials-2024 (Canada)
- Medicinal Chemistry - Naturalproducts 2024 (Italy)
- Medicinal Plant Research - Naturalproducts 2024 (Italy)
- Medicinal Plants as Anti-Cancer Drugs - Naturalproducts 2024 (Italy)
- Mental Health and Psychiatric Nursing - NURSING PHARMACOLOGY 2024 (France)
- Micro Organisms in Recent Drug Discovery - Antibiotics Resistance 2024 (Canada)
- Microbial & Environmental Biotechnology - Biotech-2025 (France)
- Microbiology Clinical Research - Clinical Research 2024 (UK)
- Minimally Invasive Heart Surgery - Cardiovascular-2024 (France)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2024 (Canada)
- Modern drug delivery techniques - Drug Safety 2024 (France)
- Molecualr Biotechnology - Biotech-2025 (France)
- Molecular and Clinical Pharmacology - Pharmacology 2024 (Netherlands)
- Molecular and Clinical Pharmacology - Euro Pharmacology 2024 (UK)
- Monoclonal Antibody Biosimilars - Eurobiosimilars 2025 (France)
- Nano medicine and Nanotechnology in Drug Delivery - Pharmaceutica-2025 (Canada)
- Nano particulate Drug Delivery Systems - PHARMACEUTICA 2024 (Italy)
- Nanomedicine and Biomedical Applications - PHARMACEUTICA 2024 (Italy)
- Nanotechnology Applications in Drug Delivery - Drug Delivery-2024 (France)
- Natural Products - Naturalproducts 2024 (Italy)
- Natural Products Chemistry - Naturalproducts 2024 (Italy)
- Natural Products in Drug Development - PHARAMACEUTICAL CONF 2024 (France)
- Neuro Pharmacology - Pharmacology 2024 (Netherlands)
- New Advances in Drug Delivery Systems - Drug Safety 2024 (France)
- New antibiotics and non-antibiotic approaches - Antibiotics Resistance 2024 (Canada)
- New Sources and Approaches to Natural Products - Naturalproducts 2024 (Italy)
- Novel Drug Delivery Systems - Future Pharma 2024 (Netherlands)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2024 (Switzerland)
- Novel Drug Delivery Technologies - Drug Delivery-2024 (France)
- Novel Drug Delivery Technologies - Pharmaceutica-2025 (Canada)
- Novel Drug Dery Systems - Formulations 2024 (Netherlands)
- Nursing Education and Practice - NURSING PHARMACOLOGY 2024 (France)
- Nursing Leadership and Professional Development - NURSING PHARMACOLOGY 2024 (France)
- Nursing Research and Evidence-Based Practice - NURSING PHARMACOLOGY 2024 (France)
- Nutraceuticals and Functional Medicine - Naturalproducts 2024 (Italy)
- Ocular Pharmacology - Pharmacology 2024 (Netherlands)
- Oncology Clinical Research - Clinical Research 2024 (UK)
- Open-Heart Surgery - Cardiovascular-2024 (France)
- Orphan Drug Therapeutics - ORPHAN DRUGS 2024 (France)
- Orphan Drugs Clinical Research - ORPHAN DRUGS 2024 (France)
- Overview on Rare Diseases - ORPHAN DRUGS 2024 (France)
- Patient Concerns for Orphan Drugs - ORPHAN DRUGS 2024 (France)
- Patient Recruiting & Retention - Clinical Research 2024 (UK)
- Patient Safety and Quality Improvement - NURSING PHARMACOLOGY 2024 (France)
- Patient-Cantered Care - Personalizedmedicine-2024 (Switzerland)
- Patient-Centric Clinical Trials - Clinical-Trials-2024 (Canada)
- Pediatric and Geriatric Bioequivalence - BABE 2024 (UAE)
- Peptide and Protein Drug Delivery - Pharmaceutica-2025 (Canada)
- Percutaneous Cardiovascular Interventions - Cardiovascular-2024 (France)
- Personalized Healthcare - Personalizedmedicine-2024 (Switzerland)
- Pharma and Biotech Financial Outlook - Future Pharma 2024 (Netherlands)
- Pharma Market Research - MedTech-2024 (Switzerland)
- Pharmaceutical Analysis - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Analysis - Future Pharma 2024 (Netherlands)
- Pharmaceutical Analysis - Formulations 2024 (Netherlands)
- Pharmaceutical and healthcare Industry - Future Pharma 2024 (Netherlands)
- Pharmaceutical Chemistry - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Chemistry - Future Pharma 2024 (Netherlands)
- Pharmaceutical Chemistry - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical Drug Discovery and Nanotechnology - Clinical Trials Congress-2024 (France)
- Pharmaceutical Excipients - Formulations 2024 (Netherlands)
- Pharmaceutical Formulation - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Formulation - Formulations 2024 (Netherlands)
- Pharmaceutical Formulation Technologies - Clinical Trials Congress-2024 (France)
- Pharmaceutical Formulations Market - Formulations 2024 (Netherlands)
- Pharmaceutical Manufacturing - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Manufacturing - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2024 (Switzerland)
- Pharmaceutical Nanotechnology - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Nanotechnology - PHARAMACEUTICAL CONF 2024 (France)
- Pharmaceutical Organic Chemistry - Clinical Trials Congress-2024 (France)
- Pharmaceutical Packaging - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Packaging and Logistics - MedTech-2024 (Switzerland)
- Pharmaceutical Process Validation - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Regulatory Affairs and Intellectual Property Rights - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Sciences - Clinical-Trials-2024 (Canada)
- Pharmaceutical Sciences - MedTech-2024 (Switzerland)
- Pharmaceutical Technology - Clinical Trials Congress-2024 (France)
- Pharmaceuticals and Drug Delivery Systems Using Nanotechnology - Drug Safety 2024 (France)
- Pharmaceutics & Pharmacotherapeutics - Future Pharma 2024 (Netherlands)
- Pharmacists Role in Patient Safety - Formulations 2024 (Netherlands)
- Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmacogenetics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenetics and Genomics - PHARMACEUTICA 2024 (Italy)
- Pharmacogenetics and Personalized Medicine - Pharmacology-2024 (France)
- Pharmacogenomics - Drug Safety 2024 (France)
- Pharmacogenomics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenomics - BIOSIMILARS-2024 (Indonesia)
- Pharmacogenomics and Personalized Medicine - PHARAMACEUTICAL CONF 2024 (France)
- Pharmacogenomics and Personalized Medicine - BABE 2024 (UAE)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2024 (Switzerland)
- Pharmacokinetic Parameters and Analysis - BABE 2024 (UAE)
- Pharmacokinetics and Pharmacodynamics - Pharmacology-2024 (France)
- Pharmacokinetics and Pharmacodynamics - Pharmaceutica-2025 (Canada)
- Pharmacokinetics and Pharmacodynamics in Drugs - PHARMACEUTICA 2024 (Italy)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics Resistance 2024 (Canada)
- Pharmacological Advances and Drug Development - NURSING PHARMACOLOGY 2024 (France)
- Pharmacological Testing - Euro Pharmacology 2024 (UK)
- Pharmacology - Pharmacology 2024 (Netherlands)
- Pharmacology - Drug Safety 2024 (France)
- Pharmacology - Euro Pharmacology 2024 (UK)
- Pharmacology & Toxicology - Antibiotics Resistance 2024 (Canada)
- Pharmacology and Toxicology - ORPHAN DRUGS 2024 (France)
- Pharmacology and Toxicology - MedTech-2024 (Switzerland)
- Pharmacology of Addiction and Substance Abuse - Pharmacology-2024 (France)
- Pharmacology of Aging and Geriatric Medicine - Pharmacology-2024 (France)
- Pharmacology of Antimicrobial Resistance - Pharmacology-2024 (France)
- Pharmacology of Cancer Immunotherapy - Pharmacology-2024 (France)
- Pharmacology of Cardiovascular Therapeutics - Pharmacology-2024 (France)
- Pharmacology of Neurodegenerative Disorders - Pharmacology-2024 (France)
- Pharmacology of Nutraceuticals and Dietary Supplements - Pharmacology-2024 (France)
- Pharmacology of Pain Management and Analgesia - Pharmacology-2024 (France)
- Pharmacology of Rare Diseases - Pharmacology-2024 (France)
- Pharmacology of Respiratory Diseases: - Pharmacology-2024 (France)
- Pharmacovigilance - Clinical Trials Congress-2024 (France)
- Pharmacovigilance and Drug Safety - Clinical Research 2024 (UK)
- Pharmacovigilance and Drug Safety - Clinical-Trials-2024 (Canada)
- Pharmacovigilance in the Era of Big Data - Pharmacology-2024 (France)
- Pharmacovigilance Significance and Scope - Pharmacology 2024 (Netherlands)
- Pharmacy and Pharmaceutical Technology - Euro Pharmacology 2024 (UK)
- Phytochemistry - Naturalproducts 2024 (Italy)
- Population Health - Personalizedmedicine-2024 (Switzerland)
- Post Marketing Surveillance - Clinical Trials Congress-2024 (France)
- Post-Clinical Trial closed communities - Clinical Trials Congress-2024 (France)
- Pre-clinical and Clinical Trails - Pharmacology 2024 (Netherlands)
- Precision Medicine - Personalizedmedicine-2024 (Switzerland)
- Precision Medicine and Pharmacogenomics - NURSING PHARMACOLOGY 2024 (France)
- Preformulation Research - Drug Safety 2024 (France)
- Public Health and Community Nursing - NURSING PHARMACOLOGY 2024 (France)
- QC & QA: Quality control and Quality assurance - MedTech-2024 (Switzerland)
- Quality by design(QbD) approach - MedTech-2024 (Switzerland)
- Quality Control and Regulatory Considerations in Drug Delivery Systems - Pharmaceutica-2025 (Canada)
- Radiation-based medicines and biotherapy - Drug Safety 2024 (France)
- Rare Diseases and Ultra Rare Diseases - ORPHAN DRUGS 2024 (France)
- Rare Genetic Diseases/Disorder - ORPHAN DRUGS 2024 (France)
- Real-World Evidence in Clinical Trials - Clinical Research 2024 (UK)
- Recent advances in drug delivery - Drug Devilvery 2024 (UAE)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2024 (Netherlands)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2024 (Netherlands)
- Recent Advances in Pharmacology and Toxicology - Euro Pharmacology 2024 (UK)
- Regenerative Medicine and Tissue Engineering - Drug Delivery-2024 (France)
- Regulatory Affairs - Formulations 2024 (Netherlands)
- Regulatory Affairs and Intellectual Property Rights - Future Pharma 2024 (Netherlands)
- Regulatory Affairs and Quality Assurance in Pharmaceutics - Pharmaceutica-2025 (Canada)
- Regulatory Affairs in Pharmaceutical Industry - PHARAMACEUTICAL CONF 2024 (France)
- Regulatory Authority Compliance - MedTech-2024 (Switzerland)
- Regulatory Considerations in Drug Development - Drug Delivery-2024 (France)
- Regulatory Updates on Biosimilars - Eurobiosimilars 2025 (France)
- Research and development in pharmaceuticals - Drug Safety 2024 (France)
- Research and Trials on Oncology and AIDS - Clinical-Trials-2024 (Canada)
- Revolutionary Changes - ORPHAN DRUGS 2024 (France)
- Safety of drugs and pharmacovigilance - Drug Safety 2024 (France)
- Safety Pharmacology - Pharmacology 2024 (Netherlands)
- Semi-Solid Dosage Forms - Formulations 2024 (Netherlands)
- Site Management Innovation - Clinical Research 2024 (UK)
- Smart Drug Delivery Systems - PHARMACEUTICA 2024 (Italy)
- Smart Drug Dery Systems - Formulations 2024 (Netherlands)
- Smart Polymers for Drug Delivery - Pharmaceutica-2025 (Canada)
- Solid Dosage Forms - Formulations 2024 (Netherlands)
- Stem Cell and Genetic Clinical Research - Clinical Research 2024 (UK)
- Sustainability and Global Health Biotechnology - Biotech-2025 (France)
- Targeted Therapies - Personalizedmedicine-2024 (Switzerland)
- Technologies for Formulation - Drug Safety 2024 (France)
- Technology in Pharma Sciences - MedTech-2024 (Switzerland)
- Telemedicine - Personalizedmedicine-2024 (Switzerland)
- The BBB for drug delivery - Drug Safety 2024 (France)
- The Future of Pharma R&D - Future Pharma 2024 (Netherlands)
- The Next Generation Approach of Antibiotics - Antibiotics Resistance 2024 (Canada)
- Therapeutic Drug Transporters - Drug Safety 2024 (France)
- Toxicological Pharmacovigilance - Euro Pharmacology 2024 (UK)
- Toxicology - Pharmacology 2024 (Netherlands)
- Toxicology - Euro Pharmacology 2024 (UK)
- Translational Research - Personalizedmedicine-2024 (Switzerland)
- Translational Research in Pharmacology and Therapeutics - NURSING PHARMACOLOGY 2024 (France)
- Types of Formulations - Formulations 2024 (Netherlands)
- USFDA Approved Biosimilars - Eurobiosimilars 2025 (France)
- Vaccine Delivery Systems - Pharmaceutica-2025 (Canada)
- Vaccine Drug Delivery Systems - PHARMACEUTICA 2024 (Italy)